博雅生物发布上半年业绩，归母净利润2.25亿元，下降28.68%

Core Insights - The company reported a revenue of 1.008 billion yuan for the first half of 2025, representing a year-on-year growth of 12.51% [1] - The net profit attributable to shareholders decreased to 225 million yuan, a decline of 28.68% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 166 million yuan, down 36.05% year-on-year [1] - The basic earnings per share stood at 0.45 yuan [1]